中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
PD-L1/TIGIT bispecific antibody showed survival advantage in animal model

文献类型:期刊论文

作者Mu, Songlin1,2; Liang, Zhijuan1,2; Wang, Yongmei1,2; Chu, Wendi1,2; Chen, Yi-Li3,4; Wang, Qi1,2; Wang, Guifeng1,2; Wang, Chunhe1,2,3
刊名CLINICAL AND TRANSLATIONAL MEDICINE
出版日期2022-05-01
卷号12期号:5页码:5
ISSN号2001-1326
DOI10.1002/ctm2.754
通讯作者Wang, Guifeng(gfwang@simm.ac.cn) ; Wang, Chunhe(wangc@simm.ac.cn)
资助项目China National Major Scientific and Technological Special Project[2019ZX09732002-006] ; National Natural Science Foundation of China[81872785] ; National Natural Science Foundation of China[81673347] ; Shanghai Municipal Commission of Science and Technology of China[17431904400] ; Shanghai Municipal Commission of Science and Technology of China[19YF1457400] ; Shanghai Municipal Commission of Science and Technology of China[21S11904500] ; Institutes for Drug Discovery and Development, Chinese Academy of Sciences[CASIMM0120202007] ; Institutes for Drug Discovery and Development, Chinese Academy of Sciences[CASIMM0120202008] ; Major Scientific and Technological Special Project of Zhongshan City[191022172638719] ; Major Scientific and Technological Special Project of Zhongshan City[210205143867019]
WOS研究方向Oncology ; Research & Experimental Medicine
语种英语
WOS记录号WOS:000791505100001
出版者JOHN WILEY & SONS LTD
源URL[http://119.78.100.183/handle/2S10ELR8/299298]  
专题中国科学院上海药物研究所
通讯作者Wang, Guifeng; Wang, Chunhe
作者单位1.Chinese Acad Sci, Biotherapeut Discovery Res Ctr, Shanghai Inst Mat Med, Shanghai 201203, Peoples R China
2.Univ Chinese Acad Sci, Beijing, Peoples R China
3.Dartsbio Pharmaceut Ltd, Zhongshan, Peoples R China
4.Shanghai Mabstone Biotechnol Ltd, Shanghai, Peoples R China
推荐引用方式
GB/T 7714
Mu, Songlin,Liang, Zhijuan,Wang, Yongmei,et al. PD-L1/TIGIT bispecific antibody showed survival advantage in animal model[J]. CLINICAL AND TRANSLATIONAL MEDICINE,2022,12(5):5.
APA Mu, Songlin.,Liang, Zhijuan.,Wang, Yongmei.,Chu, Wendi.,Chen, Yi-Li.,...&Wang, Chunhe.(2022).PD-L1/TIGIT bispecific antibody showed survival advantage in animal model.CLINICAL AND TRANSLATIONAL MEDICINE,12(5),5.
MLA Mu, Songlin,et al."PD-L1/TIGIT bispecific antibody showed survival advantage in animal model".CLINICAL AND TRANSLATIONAL MEDICINE 12.5(2022):5.

入库方式: OAI收割

来源:上海药物研究所

浏览0
下载0
收藏0
其他版本

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。